Is Mounjaro still on shortage?

FDA officially declared the tirzepatide shortage RESOLVED in October 2024. This triggered the 503A compounding wind-down — compounded tirzepatide must cease within 60 days of FDA shortage resolution declaration. Regional supply intermittency persists at some doses (5mg, 7.5mg are most common gaps). If your pharmacy is out, check: another local pharmacy, LillyDirect cash-pay ($549/month maintenance), telehealth compounders before their wind-down deadline. Brand Mounjaro is the most reliable supply path post-shortage.

Does Kaiser Permanente cover Mounjaro? Coverage, PA, and cash-pay (2026)

About Kaiser Permanente

How Kaiser Permanente handles GLP-1s

Kaiser is an integrated payer-provider system. Coverage decisions are made through internal formulary committees with their own evidence reviews.

Prior authorization

What Kaiser Permanente requires for Mounjaro

T2D + Ozempic trial or contraindication.

Step therapy

KP often requires Ozempic first.

When coverage fails

Cash-pay route

Savings card $25/mo for non-KP eligible.

Editorial notes

KP step therapy through Ozempic is common.

Other drugs on Kaiser Permanente

Kaiser Permanente Wegovy →
Kaiser Permanente Zepbound →
Kaiser Permanente Ozempic →
Kaiser Permanente Saxenda →

Mounjaro on other insurers

Aetna Mounjaro →
Blue Cross Blue Shield Mounjaro →
Cigna Mounjaro →
UnitedHealthcare Mounjaro →
Humana Mounjaro →
Anthem Mounjaro →

Editorial summary, not legal or medical advice. Insurance formularies change quarterly. Verify with your specific plan member services before relying on any single source. Copay ranges reflect typical commercial plans; your plan may differ.